Cargando…
FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
The factor that binds to the inducer of short transcripts‐1 (FBI-1) is a transcription suppressor and an important proto‐oncogene that plays multiple roles in carcinogenesis and therapeutic resistance. In the present work, our results indicated that FBI-1 enhanced the resistance of triple-negative b...
Autores principales: | Yang, Hua, Ren, Lili, Wang, Yanan, Bi, Xuebing, Li, Xiaoli, Wen, Ming, Zhang, Qian, Yang, Yang, Jia, Youchao, Li, Yumiao, Zang, Aimin, wei, Yaning, Dai, Guanghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554048/ https://www.ncbi.nlm.nih.gov/pubmed/33051436 http://dx.doi.org/10.1038/s41419-020-03053-0 |
Ejemplares similares
-
Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance
por: Niu, Xiaxia, et al.
Publicado: (2022) -
CRISPR/Cas9-induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer
por: Yang, Hua, et al.
Publicado: (2022) -
Biosecurity in the age of Big Data: a conversation with the FBI
por: Kozminski, Keith G.
Publicado: (2015) -
PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome
por: Hukkanen, Janne, et al.
Publicado: (2020) -
Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis
por: Qin, Mengyao, et al.
Publicado: (2022)